At present, the commonly used plasma biomarkers in CRC detection are carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), but the practical application of both is limited due to their low sensitivity and specificity [108,109]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.